Transformative technology sectors remain in early adoption phases

Conviction: 62% · Horizon: 10Y · 2026-07-04
Biotech commercialization and platform scale-up are still ahead of peak penetration

Gene editing, cell therapies, and programmable biology are moving from proof-of-concept to broader therapeutic and industrial use cases, with regulatory pathways and manufacturing still maturing. Revenue and adoption curves suggest the sector has years of compound growth before saturation.

Instrument Side Target Reason
XBI Long We believe a diversified biotech basket captures upside from pipeline maturation and expanding addressable markets while spreading single-trial binary risk.
Robotics deployment in logistics, manufacturing, and services is still pre-mass adoption

Labor cost pressure, AI-driven perception, and falling actuator costs are converging to make autonomous manipulation economical across warehouses, factories, and field operations. Installed base and capex cycles imply a long runway before robotics becomes commoditized infrastructure.

Instrument Side Target Reason
BOTZ Long We believe global robotics and AI automation exposure benefits from recurring capex upgrades as humanoid and mobile systems move from pilots to line-scale deployment.
Photonics is becoming critical infrastructure for bandwidth, sensing, and compute interconnect

Optical components underpin data-center scale-out, lidar, telecom upgrades, and advanced metrology. Demand growth from AI clusters and 5G/6G backhaul is outpacing legacy copper and discrete electronic solutions, with the supply chain still consolidating around specialized fabs and packaging.

Instrument Side Target Reason
LITE Long We believe leading optical module and laser suppliers sit at the choke point for high-speed interconnect and sensing volumes tied to AI infrastructure buildouts.
AI applications layer is underbuilt relative to model and compute investment

Foundation models and GPUs have absorbed capital first; enterprise workflow software, vertical copilots, and agentic automation remain early in monetization and penetration. Margin capture is likely to shift toward software that embeds models into regulated, high-friction industries over the next cycle.

Instrument Side Target Reason
IGPT Long We believe a concentrated basket of AI-native software and platform names offers leverage to application-layer revenue as inference costs fall and productization accelerates.

Themes

The content on this page is for informational purposes only and does not constitute financial advice. Stoquate is not a licensed financial advisor. Always conduct your own research and consult a qualified professional before making any investment decisions.